Suppression of Netrin-1 attenuates angiotension II-induced cardiac remodeling through the PKC/MAPK signaling pathway.

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Gaojun WuZhouqing Huang

Abstract

Myocardial remodeling caused by angiotensin II (Ang II) is essential for the pathological process of heart failure. Netrin-1, which is an axonal guidance cue, has been shown to be involved in the inflammatory response, tumorigenesis, and angiogenesis in non-neuronal tissues. However, the role of Netrin-1 in cardiac remodeling has not been fully elucidated. The rat cardiomyocyte cell line H9c2 and primary neonatal rat cardiomyocytes were treated with Ang II. Cells were transfected with siRNA to silence Netrin-1 expression. Real-time polymerase chain reaction and Western blot analysis were used to detect the markers for fibrosis, apoptosis, and hypertrophy in cardiomyocytes. An Annexin V-EGFP/PI cell apoptosis detection kit was used to measure the level of apoptosis caused by angiotensin II. We found that Netrin-1 expression was upregulated in the H9c2 cells and the neonatal rat cardiomyocytes stimulated by Ang II. The increased Netrin-1 expression was decreased by valsartan to block AT1R. Importantly, the application of Netrin-1 siRNA significantly alleviated the degrees of myocardial hypertrophy, fibrosis (reflected by Myhc, collagen I, and TGF-β) and apoptosis (reflected by the level of Caspase 3, Bax, and Bcl-2) induced by An...Continue Reading

References

Apr 6, 2000·The American Journal of Cardiology·T YamazakiY Yazaki
May 29, 2001·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Z KaprielianR Imondi
Jun 2, 2001·The EMBO Journal·F LlambiP Mehlen
Feb 20, 2002·Journal of Molecular and Cellular Cardiology·Alfonso BaldiGermano Di Sciascio
Feb 18, 2004·Hypertension·Gunter Wolf, Ulrich O Wenzel
Jul 28, 2004·Cardiovascular Research·Stephan Rosenkranz
Nov 3, 2004·Proceedings of the National Academy of Sciences of the United States of America·Kye Won ParkDean Y Li
Jan 25, 2005·Cardiovascular Research·Monica AutieroPeter Carmeliet
Oct 6, 2005·Proceedings of the National Academy of Sciences of the United States of America·Ngoc P LyT Bernard Kinane
Mar 24, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Joseph L BartoeLindsay Hinck
Jul 28, 2006·American Journal of Physiology. Cell Physiology·Puja K Mehta, Kathy K Griendling
Mar 21, 2008·Proceedings of the National Academy of Sciences of the United States of America·Julien FitamantPatrick Mehlen
Sep 2, 2009·Proceedings of the National Academy of Sciences of the United States of America·Andrea ParadisiPatrick Mehlen
Oct 25, 2011·Journal of the American College of Cardiology·Arantxa GonzálezJavier Díez
Jan 10, 2012·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·Clinton D Kemp, John V Conte
Mar 21, 2012·Antioxidants & Redox Signaling·Daniela Zablocki, Junichi Sadoshima
Jul 20, 2012·Circulation·Thomas Thum, Johan M Lorenzen
May 28, 2014·The Journal of Experimental Medicine·Valbona MirakajCharles N Serhan
Jul 26, 2015·Cardiovascular Research·Kerry LayneGabriella Passacquale
Sep 12, 2015·Circulation Research·Sujith Dassanayaka, Steven P Jones
Feb 28, 2016·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Sophie MathieuCéline Fiset
May 22, 2017·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Tatsuo KawaiSatoru Eguchi
Jul 29, 2017·Oxidative Medicine and Cellular Longevity·Leonardo SchironeGiacomo Frati

❮ Previous
Next ❯

Citations

May 4, 2021·Molecular Nutrition & Food Research·Xueqin FengDongmei Man
Sep 3, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Ding-Yan LuTing Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis